🆓 Free Public Citation & Sample Record #1 (clinical-trials.withsilex.com)
Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension
{
"nct_id": "NCT07650084",
"title": "A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension",
"status": "TERMINATED",
"phase": "PHASE3",
"conditions": "Refractory Chronic Cough",
"verify_url": "https://clinicaltrials.gov/study/NCT07650084"
}
🔓 UNLOCKED WHOLE KEYWORD LIBRARY (3 DATASETS)
{"id":"pulse_clinical-trials_20261120-1330","url":"https://clinical-trials.withsilex.com/v1/pulse/nct-nct07650084-phase3-a-24-week-study-of-the-efficacy-a-1120-1330z","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"b33b27679b6eda78076cc9946056620634e5445efdc5ff7c89bf333f8cb19d3e","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-20T13:30:46.603Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","executive_summary":"Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07650084, NCT07951593, NCT07950592)","delta_changed_count":6,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT07650084","title":"A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","status":"TERMINATED","phase":"PHASE3","conditions":"Refractory Chronic Cough","verify_url":"https://clinicaltrials.gov/study/NCT07650084"},{"nct_id":"NCT07951593","title":"Nurse-Led SKIN CARE Bundle on Medical Device-Related Pressure Injuries","status":"COMPLETED","phase":"NA","conditions":"Pressure Ulcer (PU)","verify_url":"https://clinicaltrials.gov/study/NCT07951593"},{"nct_id":"NCT07950592","title":"The ABODE Study for Patients Undergoing Neoadjuvant Chemotherapy","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Breast Cancer and Rehabilitation; Breast Cancer (Early Breast Cancer); Breast Cancer - Female","verify_url":"https://clinicaltrials.gov/study/NCT07950592"},{"nct_id":"NCT06215287","title":"Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Mat","status":"COMPLETED","phase":"OBSERVATIONAL","conditions":"Chronic Iron Overload","verify_url":"https://clinicaltrials.gov/study/NCT06215287"},{"nct_id":"NCT07631871","title":"An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy","status":"RECRUITING","phase":"PHASE2","conditions":"Neoplasms; Solid Tumors; HER2 Positive Solid Tumor","verify_url":"https://clinicaltrials.gov/study/NCT07631871"},{"nct_id":"NCT07075055","title":"Impact of a New Bioceramic Based Intracanal Medication","status":"COMPLETED","phase":"NA","conditions":"Post Operative Pain","verify_url":"https://clinicaltrials.gov/study/NCT07075055"}],"signal_sha256":"b33b27679b6eda78076cc9946056620634e5445efdc5ff7c89bf333f8cb19d3e"}}
{"id":"synth_biomed-fda-grants_20261120-1330","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261120-1330","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"f227682b756efd888e5fc9c26278e4f0e57e3ac2b8645e0d2d17b773315914c8","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-20T13:30:46.603Z","slot_compact":"20261120-1330","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic... | [cold-chain] Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157...","delta_since_last_slot":"clinical-trials: +6 new primary record(s) since prior slot (NCT07650084, NCT079515 · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07650084, NCT07951593, NCT07950592)","what_happened":"Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","top_records":[{"nct_id":"NCT07650084","title":"A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","status":"TERMINATED","phase":"PHASE3","conditions":"Refractory Chronic Cough","verify_url":"https://clinicaltrials.gov/study/NCT07650084"},{"nct_id":"NCT07951593","title":"Nurse-Led SKIN CARE Bundle on Medical Device-Related Pressure Injuries","status":"COMPLETED","phase":"NA","conditions":"Pressure Ulcer (PU)","verify_url":"https://clinicaltrials.gov/study/NCT07951593"},{"nct_id":"NCT07950592","title":"The ABODE Study for Patients Undergoing Neoadjuvant Chemotherapy","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Breast Cancer and Rehabilitation; Breast Cancer (Early Breast Cancer); Breast Cancer - Female","verify_url":"https://clinicaltrials.gov/study/NCT07950592"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157 STEC).","top_records":[{"recall_number":"H-0197-2027","firm":"Family Farmstead Dairy, LLC","classification":"Class I","location":"Worcester, NY","report_date":"20261111","reason":"Potential contamination with E. coli (pathogenic non-O157 STEC)."},{"recall_number":"H-0192-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"},{"recall_number":"H-0191-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"79481-0419","generic_name":"ibuprofen","brand_name":"CHILDRENS IBUPROFEN","dosage_form":"TABLET, CHEWABLE","labeler":"Meijer, Inc.","marketing_category":"ANDA"},{"product_ndc":"77771-182","generic_name":"Hydralazine Hydrochloride","brand_name":"Hydralazine Hydrochloride","dosage_form":"TABLET","labeler":"Radha Pharmaceuticals, Inc.","marketing_category":"ANDA"},{"product_ndc":"78863-1040","generic_name":"Salicylic Acid and Benzoyl Peroxide","brand_name":"Double Fight","dosage_form":"KIT","labeler":"Noon Aesthetics M.R. Ltd","marketing_category":"OTC MONOGRAPH DRUG"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"f227682b756efd888e5fc9c26278e4f0e57e3ac2b8645e0d2d17b773315914c8"}}
{"id":"synth_biomed-fda-grants_20261120-1345","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261120-1345","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"cff2f490ba569b785ca146a0821f5a627f539df381fdf1f5aa3328dbe14fe897","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-20T13:45:51.574Z","slot_compact":"20261120-1345","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic... | [cold-chain] Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157...","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","top_records":[{"nct_id":"NCT07650084","title":"A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","status":"TERMINATED","phase":"PHASE3","conditions":"Refractory Chronic Cough","verify_url":"https://clinicaltrials.gov/study/NCT07650084"},{"nct_id":"NCT07951593","title":"Nurse-Led SKIN CARE Bundle on Medical Device-Related Pressure Injuries","status":"COMPLETED","phase":"NA","conditions":"Pressure Ulcer (PU)","verify_url":"https://clinicaltrials.gov/study/NCT07951593"},{"nct_id":"NCT07950592","title":"The ABODE Study for Patients Undergoing Neoadjuvant Chemotherapy","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Breast Cancer and Rehabilitation; Breast Cancer (Early Breast Cancer); Breast Cancer - Female","verify_url":"https://clinicaltrials.gov/study/NCT07950592"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157 STEC).","top_records":[{"recall_number":"H-0197-2027","firm":"Family Farmstead Dairy, LLC","classification":"Class I","location":"Worcester, NY","report_date":"20261111","reason":"Potential contamination with E. coli (pathogenic non-O157 STEC)."},{"recall_number":"H-0192-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"},{"recall_number":"H-0191-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"79481-0419","generic_name":"ibuprofen","brand_name":"CHILDRENS IBUPROFEN","dosage_form":"TABLET, CHEWABLE","labeler":"Meijer, Inc.","marketing_category":"ANDA"},{"product_ndc":"77771-182","generic_name":"Hydralazine Hydrochloride","brand_name":"Hydralazine Hydrochloride","dosage_form":"TABLET","labeler":"Radha Pharmaceuticals, Inc.","marketing_category":"ANDA"},{"product_ndc":"78863-1040","generic_name":"Salicylic Acid and Benzoyl Peroxide","brand_name":"Double Fight","dosage_form":"KIT","labeler":"Noon Aesthetics M.R. Ltd","marketing_category":"OTC MONOGRAPH DRUG"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"cff2f490ba569b785ca146a0821f5a627f539df381fdf1f5aa3328dbe14fe897"}}
clinical-trials.withsilex.com · 2026-11-20 13:30 UTC · Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in